Netupitant/palonosetron (NEPA) and dexamethasone for prevention of emesis in breast cancer patients receiving adjuvant anthracycline plus cyclophosphamide: a multi-cycle, phase II study.
Caputo R, Cazzaniga ME, Sbrana A, Torrisi R, Paris I, Giordano M, Montesarchio V, Guarneri V, Amaducci L, Bilancia D, Cilenti G, Fabi A, Collovà E, Schirone A, Bonizzoni E, Celio L, De Placido S, De Laurentiis M.
Caputo R, et al. Among authors: celio l.
BMC Cancer. 2020 Mar 19;20(1):232. doi: 10.1186/s12885-020-6707-9.
BMC Cancer. 2020.
PMID: 32188417
Free PMC article.
Clinical Trial.